BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26457576)

  • 1. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
    Rivas-Delgado A; Matutes E; Rozman M
    Br J Haematol; 2016 Feb; 172(4):495. PubMed ID: 26457576
    [No Abstract]   [Full Text] [Related]  

  • 2. Pure Red Cell Aplasia Due to Parvovirus B19: Erythropoietin-Resistant Anemia in a Pediatric Kidney Recipient.
    Malbora B; Saritas S; Ataseven E; Belen B; Alparslan C; Yavascan O; Yilmaz Ciftdogan D; Atabay B; Turker M
    Exp Clin Transplant; 2017 Jun; 15(3):369-371. PubMed ID: 28387173
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful re-transplantation in patient with recurrent parvovirus B19 pure red cell aplasia.
    Inamdar N; Nada R; Minz R; Kenwar DB; Singh S; Sharma A; Kumar V; Rathi M; Kohli HS; Ramachandran R
    Transpl Infect Dis; 2019 Dec; 21(6):e13164. PubMed ID: 31483919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Cases of Kidney Transplant Recipients With Multiple Relapsing Pure Red Cell Aplasia Due to Parvovirus B19 Infection.
    Ersal T; Özkalemkaş F; Özkocaman V; Sezen M; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Koca TG
    Exp Clin Transplant; 2024 Jan; 22(1):75-79. PubMed ID: 36259607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
    Kaya B; Paydas S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.
    Sturm I; Watschinger B; Geissler K; Guber SE; Popow-Kraupp T; Horl WH; Pohanka E
    Nephrol Dial Transplant; 1996 Jul; 11(7):1367-70. PubMed ID: 8672044
    [No Abstract]   [Full Text] [Related]  

  • 8. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin.
    Ramage JK; Hale A; Gane E; Cohen B; Boyle M; Mufti G; Williams R
    Lancet; 1994 Mar; 343(8898):667-8. PubMed ID: 7906821
    [No Abstract]   [Full Text] [Related]  

  • 9. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
    Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
    Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of recurrent anemia due to chronic parvovirus B19 infection in a kidney transplant recipient. Can everolimus make a difference?
    Rodríguez-Espinosa D; Esforzado N; Hermida E; Cuadrado E; Broseta JJ; Diekmann F; Revuelta I
    CEN Case Rep; 2021 Aug; 10(3):388-392. PubMed ID: 33539009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus-B19-associated complications in renal transplant recipients.
    Waldman M; Kopp JB
    Nat Clin Pract Nephrol; 2007 Oct; 3(10):540-50. PubMed ID: 17895931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red-cell aplasia due to parvovirus B19 infection in a patient with AIDS-related complex.
    Taillan B; Heudier P; Ferrari E; Garnier G; Fuzibet JG; Dujardin P
    Ann Med; 1992 Apr; 24(2):137. PubMed ID: 1610541
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation.
    Koda Y; Mori T; Kato J; Kohashi S; Kikuchi T; Mitsuhashi T; Murata M; Uemura T; Handa M; Okamoto S
    Transpl Infect Dis; 2013 Dec; 15(6):E239-42. PubMed ID: 24134728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Treatment of Anemia With Anaplastic and Microangiopathic Characteristics in a Kidney Transplant Recipient With Parvovirus B19 Infection: A Case Report.
    Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
    Transplant Proc; 2020 Jun; 52(5):1619-1622. PubMed ID: 32389489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
    Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
    Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure Red Cell Aplasia and Antibody-Mediated Rejection: Double Trouble in 1 Kidney Transplant Recipient Solved by Intravenous Immunoglobulin Infusion: A Case Report.
    Knysak M; Napora M; Misiukiewicz-Poć M; Pawłowska A; Kwella N; Zbrzeźniak J; Winiarska A; Stompór T
    Transplant Proc; 2020 Oct; 52(8):2530-2532. PubMed ID: 32276841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.
    Corral DA; Darras FS; Jensen CW; Hakala TR; Naides SJ; Krause JR; Starzl TE; Jordan ML
    Transplantation; 1993 Feb; 55(2):427-30. PubMed ID: 8434395
    [No Abstract]   [Full Text] [Related]  

  • 19. Pure Red Cell Aplasia After Kidney Transplantation: Parvovirus B19 Culprit or Coincidence?
    Pabisiak K; Stępniewska J; Ciechanowski K
    Ann Transplant; 2019 Mar; 24():123-131. PubMed ID: 30833537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient.
    Alonci A; Penna G; Allegra A; D'Angelo A; Gangemi S; Ferraro M; Spatari G; Bacci F; Gerace D; Musolino C
    Acta Oncol; 2011 May; 50(4):599-602. PubMed ID: 21529302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.